Emel Gürkan

438 total citations
32 papers, 267 citations indexed

About

Emel Gürkan is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Emel Gürkan has authored 32 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Genetics and 5 papers in Oncology. Recurrent topics in Emel Gürkan's work include Chronic Lymphocytic Leukemia Research (9 papers), Hemoglobinopathies and Related Disorders (8 papers) and Platelet Disorders and Treatments (4 papers). Emel Gürkan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Hemoglobinopathies and Related Disorders (8 papers) and Platelet Disorders and Treatments (4 papers). Emel Gürkan collaborates with scholars based in Türkiye, United States and Hungary. Emel Gürkan's co-authors include Fikri Başlamıslı, Kahraman Tanrıverdi, Birol Güvenç, Zeynep Kekeç, Semra Paydaş, Tamer Tetıker, Carlos A. Ramos, Marcos de Lima, Benjamin Lichtiger and Richard Champlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

Emel Gürkan

29 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emel Gürkan Türkiye 12 147 117 39 39 29 32 267
Caroline R. Alquist United States 5 75 0.5× 42 0.4× 16 0.4× 64 1.6× 24 0.8× 16 250
A Indovina Italy 12 247 1.7× 71 0.6× 54 1.4× 82 2.1× 42 1.4× 29 448
Ìhsan Karadoǧan Türkiye 10 88 0.6× 36 0.3× 27 0.7× 24 0.6× 31 1.1× 26 250
John Bæch Denmark 10 103 0.7× 39 0.3× 65 1.7× 70 1.8× 8 0.3× 20 298
Stephen F. Wallner United States 13 162 1.1× 126 1.1× 55 1.4× 68 1.7× 86 3.0× 21 388
Sangeeta Krishnan United States 13 360 2.4× 77 0.7× 39 1.0× 57 1.5× 23 0.8× 32 659
C. Brunati Italy 9 69 0.5× 42 0.4× 61 1.6× 15 0.4× 16 0.6× 25 230
Nilgün Sayınalp Türkiye 11 62 0.4× 33 0.3× 50 1.3× 29 0.7× 23 0.8× 28 311
F. R. Rosendaal Netherlands 9 311 2.1× 58 0.5× 18 0.5× 25 0.6× 23 0.8× 10 447
Farjah Algahtani Saudi Arabia 10 125 0.9× 113 1.0× 28 0.7× 8 0.2× 18 0.6× 43 283

Countries citing papers authored by Emel Gürkan

Since Specialization
Citations

This map shows the geographic impact of Emel Gürkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Gürkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Gürkan more than expected).

Fields of papers citing papers by Emel Gürkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emel Gürkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Gürkan. The network helps show where Emel Gürkan may publish in the future.

Co-authorship network of co-authors of Emel Gürkan

This figure shows the co-authorship network connecting the top 25 collaborators of Emel Gürkan. A scholar is included among the top collaborators of Emel Gürkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emel Gürkan. Emel Gürkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gürkan, Emel, et al.. (2025). Venotoclax associated hypothyroidism in a patient with acute myeloid leukemia. Journal of Oncology Pharmacy Practice. 31(6). 1011–1013.
3.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
4.
Paydaş, Semra, Şahin Laçin, Mutlu Doğan, et al.. (2021). IPS-3 Validation in 1012 cases with classical hodgkin lymphoma. Leukemia Research. 102. 106519–106519. 1 indexed citations
5.
Deveci, Onur Sinan, et al.. (2021). Increased Circulating Copeptin Levels Are Associated with Vaso-Occlusive Crisis and Right Ventricular Dysfunction in Sickle Cell Anemia. Medical Principles and Practice. 31(1). 47–53. 2 indexed citations
6.
Açıkalın, Arbil, et al.. (2017). Prevalence of cytogenetic abnormalities in chronic lymphocytic leukemia in the southern part of Turkey. Indian Journal of Cancer. 54(3). 572–572. 1 indexed citations
7.
Asma, Süheyl, Çiğdem Gereklioğlu, Selma Ünal, et al.. (2016). East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Annals of Hematology. 95(6). 993–1000. 23 indexed citations
8.
Tombak, Anıl, Naci Tiftik, Güray Saydam, et al.. (2015). Seasonal Association of Immune Thrombocytopenia in Adults. DergiPark (Istanbul University).
9.
Tombak, Anıl, Naci Tiftik, Ozan Salim, et al.. (2015). Seasonal Association of Immune Thrombocytopenia in Adults. Balkan Medical Journal. 32(4). 347–351. 4 indexed citations
10.
Paydaş, Saime, Semra Paydaş, Mustafa Balal, et al.. (2013). Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers. SHILAP Revista de lepidopterología. 30(3). 315–320. 1 indexed citations
11.
Illyés, Miklós, et al.. (2013). Arterial Stiffness and Pulse Wave Reflection in Young Adult Heterozygous Sickle Cell Carriers. SHILAP Revista de lepidopterología. 30(4). 379–386. 4 indexed citations
12.
Taşova, Yeşim, Filiz Kibar, Sinan Yavuz, et al.. (2010). Hospital-Acquired Bloodstream Infections in Cancer Patients between 2005 and 2007 in a Turkish University Hospital.. 1(2). 1 indexed citations
13.
Gürkan, Emel, Poliana Patah, Rima M. Saliba, et al.. (2007). Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 40(5). 461–464. 23 indexed citations
14.
Gürkan, Emel, Kahraman Tanrıverdi, & Fikri Başlamıslı. (2005). Telomerase activity in myelodysplastic syndromes. Leukemia Research. 29(10). 1131–1139. 27 indexed citations
15.
Gürkan, Emel, et al.. (2005). Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases. Clinical & Laboratory Haematology. 27(2). 121–125. 13 indexed citations
16.
Gürkan, Emel, et al.. (2005). Avascular necrosis of the femoral head as the first manifestation of acute lymphoblastic leukemia. Leukemia & lymphoma. 47(2). 365–367. 10 indexed citations
17.
Gürkan, Emel, et al.. (2005). Liver involvement in sickle cell disease.. PubMed. 16(4). 194–8. 15 indexed citations
18.
Gürkan, Emel, Kahraman Tanrıverdi, & Fikri Başlamıslı. (2004). Clinical relevance of vascular endothelial growth factor levels in sickle cell disease. Annals of Hematology. 84(2). 71–75. 18 indexed citations
19.
Gürkan, Emel, et al.. (2004). Budd-Chiari Syndrome Associated with Visceral Leishmaniasis and Factor V Leiden Mutation. Journal of Thrombosis and Thrombolysis. 18(3). 205–207. 2 indexed citations
20.
Gürkan, Emel, et al.. (2003). Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections. American Journal of Hematology. 74(1). 52–54. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline R. Alquist Breakdown of academic impact, for papers by A Indovina Breakdown of academic impact, for papers by Ìhsan Karadoǧan Breakdown of academic impact, for papers by John Bæch Breakdown of academic impact, for papers by Stephen F. Wallner Breakdown of academic impact, for papers by Sangeeta Krishnan Breakdown of academic impact, for papers by C. Brunati Breakdown of academic impact, for papers by Nilgün Sayınalp Breakdown of academic impact, for papers by F. R. Rosendaal Breakdown of academic impact, for papers by Farjah Algahtani
Rankless by CCL
2026